Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Exp Mol Pathol. 2010 Apr 28;89(1):1–8. doi: 10.1016/j.yexmp.2010.04.001

Fig 2.

Fig 2

Effects of NFkB, JNK and p38 inhibitors on the expression of UbD and immunoproteasome catalytic subunits induced by TNFa and IFNg. (n=4) (Statistics for UbD: Control vs. I+T p=0.002; I+T vs. I+T+NFkBi p=0.005; I+T vs. I+T+SP600125 p=0.002; I+T vs. IT+SB202190 p=0.002; for MECL-1: I+T vs. Control p<0.001; I+T vs. I+T+SB202190 p<0.001; for LMP2: Control vs. I+T p=0.043; I+T vs. I+T+SB202190 p=0.096; for LMP7: Control vs. I+T p=0.044; I+T vs. I+T+SB202190 p=0.045. (I+T : IFNg + TNFa).